Penn Memory Center researchers look at the future of Alzheimer’s detection
A direct-to-consumer blood test for a key Alzheimer’s biomarker may be inevitable, but Penn Program on Precision Medicine for the Brain researchers Jason Karlawish, Emily Largent, and Anna Wexler warn that receiving results from such a test comes with potential challenges. The team weigh the risks and benefits of these blood tests in an article for JAMA Neurology titled “The Future is p-Tau—Anticipating Direct-to-Consumer Alzheimer’s Disease Blood Tests.”
FULL STORY AT Penn Memory Center →